Cargando…
One-year infliximab administration for the treatment of chronic refractory pouchitis
AIM: To determine the efficacy of infliximab in the treatment of chronic refractory pouchitis, following ileo-pouch anal anastomosis (IPAA) for ulcerative colitis (UC). METHODS: Seven patients (4 females, 3 males) with chronic refractory pouchitis were included in an open study. Pouchitis was diagno...
Autores principales: | Viazis, Nikos, Giakoumis, Marios, Koukouratos, Theodoros, Saprikis, Efstathios, Anastasopoulos, Elias, Al-Odat, Mousa, Kechagias, Georgios, Zacharakis, Georgios, Markoglou, Konstantinos, Gouma, Paraskevi, Karamanolis, Demetrios G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959330/ https://www.ncbi.nlm.nih.gov/pubmed/24713783 |
Ejemplares similares
-
Immune response to hepatitis B vaccine in patients who lost hepatitis B surface antigen during follow up
por: Zacharakis, Georgios, et al.
Publicado: (2011) -
Successful Long-Term Use of Infliximab in Refractory Pouchitis in an Adolescent
por: Yeates, Jessica, et al.
Publicado: (2010) -
Pyoderma gangrenosum associated with chronic refractory pouchitis: a case successfully treated with infliximab
por: Koumaki, Dimitra, et al.
Publicado: (2020) -
Vedolizumab for chronic antibiotic-refractory pouchitis
por: Singh, Amandeep, et al.
Publicado: (2019) -
Chronic Antibiotic-Refractory Pouchitis: Management Challenges
por: Outtier, An, et al.
Publicado: (2021)